Shafat I - Search Results

1

Heparanase: one molecule with multiple functions in cancer progression.

Vlodavsky I, Elkin M, Abboud-Jarrous G, Levi-Adam F, Fuks L, Shafat I, Ilan N. Vlodavsky I, et al. Among authors: shafat i. Connect Tissue Res. 2008;49(3):207-10. doi: 10.1080/03008200802143281. Connect Tissue Res. 2008. PMID: 18661344 Review.

2

An ELISA method for the detection and quantification of human heparanase.

Shafat I, Zcharia E, Nisman B, Nadir Y, Nakhoul F, Vlodavsky I, Ilan N. Shafat I, et al. Biochem Biophys Res Commun. 2006 Mar 24;341(4):958-63. doi: 10.1016/j.bbrc.2006.01.048. Epub 2006 Jan 24. Biochem Biophys Res Commun. 2006. PMID: 16458254 Free PMC article.

3

Characterization of mechanisms involved in secretion of active heparanase.

Shafat I, Vlodavsky I, Ilan N. Shafat I, et al. J Biol Chem. 2006 Aug 18;281(33):23804-11. doi: 10.1074/jbc.M602762200. Epub 2006 Jun 20. J Biol Chem. 2006. PMID: 16790442 Free article.

4

Heparanase up-regulation in tongue cancer: tissue and saliva analysis.

Nagler R, Ben-Izhak O, Cohen-Kaplan V, Shafat I, Vlodavsky I, Akrish S, Ilan N. Nagler R, et al. Among authors: shafat i. Cancer. 2007 Dec 15;110(12):2732-9. doi: 10.1002/cncr.23095. Cancer. 2007. PMID: 17955520 Free article.

5

Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment.

Shafat I, Barak AB, Postovsky S, Elhasid R, Ilan N, Vlodavsky I, Arush MW. Shafat I, et al. Neoplasia. 2007 Nov;9(11):909-16. doi: 10.1593/neo.07673. Neoplasia. 2007. PMID: 18030359 Free PMC article.

6

Clinical significance of urine heparanase in bladder cancer progression.

Shafat I, Pode D, Peretz T, Ilan N, Vlodavsky I, Nisman B. Shafat I, et al. Neoplasia. 2008 Feb;10(2):125-30. doi: 10.1593/neo.07875. Neoplasia. 2008. PMID: 18283334 Free PMC article.

7

The heparanase system and tumor metastasis: is heparanase the seed and soil?

Arvatz G, Shafat I, Levy-Adam F, Ilan N, Vlodavsky I. Arvatz G, et al. Among authors: shafat i. Cancer Metastasis Rev. 2011 Jun;30(2):253-68. doi: 10.1007/s10555-011-9288-x. Cancer Metastasis Rev. 2011. PMID: 21308479 Review.

8

Low and high affinity receptors mediate cellular uptake of heparanase.

Ben-Zaken O, Shafat I, Gingis-Velitski S, Bangio H, Kelson IK, Alergand T, Amor Y, Maya RB, Vlodavsky I, Ilan N. Ben-Zaken O, et al. Among authors: shafat i. Int J Biochem Cell Biol. 2008;40(3):530-42. doi: 10.1016/j.biocel.2007.09.003. Epub 2007 Sep 29. Int J Biochem Cell Biol. 2008. PMID: 17981072 Free PMC article.

9

Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant.

Nasser NJ, Nevo E, Shafat I, Ilan N, Vlodavsky I, Avivi A. Nasser NJ, et al. Among authors: shafat i. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15161-6. doi: 10.1073/pnas.0507279102. Epub 2005 Oct 4. Proc Natl Acad Sci U S A. 2005. PMID: 16204381 Free PMC article.

10

Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis.

Nasser NJ, Avivi A, Shafat I, Edovitsky E, Zcharia E, Ilan N, Vlodavsky I, Nevo E. Nasser NJ, et al. Among authors: shafat i. Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2253-8. doi: 10.1073/pnas.0812846106. Epub 2009 Jan 21. Proc Natl Acad Sci U S A. 2009. PMID: 19164514 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page